Latest News

syringes | Image credit: SOPONE -
Julie Reed: Why 2024 Is Important for Biosimilars

April 17th 2024

Julie Reed, executive director of the Biosimilars Forum, showcases how the biosimilar industry is expected to develop throughout 2024, including major policy changes and hope for continued improvement in market share for adalimumab biosimilars.

FDA building | Image credit: JHVEPhoto -
Alvotech’s Stelara Biosimilar, Selarsdi, Receives FDA Approval

April 16th 2024

syringe and doctor | Image credit: New Africa -
Biosimilars Council: PBM Rebate Schemes Cost Americans, Payers $6 Billion

April 10th 2024

biosimilars check-in banner
Biosimilar Business Recap: BI Layoffs; Teva, mAbxience Partnership; Phase 3 Keytruda Biosimilar Trial

April 8th 2024

data | Image credit: apinan -
Meta-Analysis Confirms Similar Safety, Efficacy Between Adalimumab Biosimilars, Humira

April 6th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.